All cystic fibrosis articles
-
NewsMHRA highlights liver injury risk with combination therapy for cystic fibrosis
The MHRA has issued a drug safety update highlighting the risk of serious liver injury following treatment with a combination therapy for cystic fibrosis
-
News
Wider approval for ‘life-changing’ cystic fibrosis drug
The licence for Kaftrio (ivacaftor/tezacaftor/elexacaftor), a disease-modulating therapy for cystic fibrosis, has now been extended to children aged under 12 years
-
News
Difficulties in accessing cystic fibrosis medications
A survey of healthcare professionals and patients with cystic fibrosis reveals problems in prescribing and accessing medications
